Advertisement

Injection Therapy: Intra-articular Platelet-Rich Plasma and Stem Cell Therapy

  • Yusuf H. MirzaEmail author
  • Sam Oussedik
Chapter

Abstract

Platelet-rich plasma (PRP) has been touted in the sports medicine and orthopaedic surgery communities as a remedy with the ability to bridge the gap between conservative, pain relieving therapies and surgical interventions. Its theoretical advantages include its ability to enhance wound healing, decrease pain and improve function.

There has also been much excitement about the multipotential nature of mesenchymal stem cells (MSCs), with the potential to regenerate different types of musculoskeletal tissue from cartilage to meniscus.

Problems with both therapies abound. As yet, there is no common consensus as to what constitutes PRP, its preparation, or the method of its activation. Similarly, MSCs can have multiple origins, be induced in different methods and delivered in a variety of forms. Thus, at present, the evidence to substantiate the claims of either therapy is sparse or fails to be robust enough to support the arguments for its use.

Our chapter provides an evidence-based insight into the background, preparation and clinical use of both PRP and MSCs, two therapies which have much to offer in regenerating and preserving tissue within the adult knee.

Keywords

Platelet-rich plasma PRP Mesenchymal stem cells Stem cells MSCs Knee 

References

  1. 1.
    Wasterlain AS, Braun HJ, Harris AHS, Kim H-J, Dragoo JL (2013) The systemic effects of platelet-rich plasma injection. Am J Sports Med 41:186–193CrossRefPubMedGoogle Scholar
  2. 2.
    Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofacial Surg 62:489–496CrossRefGoogle Scholar
  3. 3.
    Alsousou J, Thompson M, Hulley P, Noble A, Willett K (2009) The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature. J Bone Joint Surg Br 91:987–996CrossRefPubMedGoogle Scholar
  4. 4.
    Metcalf KB, Mandelbaum BR, McIlwraith CW (2013) Application of platelet-rich plasma to disorders of the knee joint. Cartilage 4:295–312CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Coller BS (2011) Historical perspective and future directions in platelet research. J Thromb Haemost 9(Suppl 1):374–395CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Eppley B L, Pietrzak W S, Blanton M (2006) Platelet-rich plasma: a review of biology and applications in plastic surgery. Plastic Reconstruct Surg 118:147e–59eGoogle Scholar
  7. 7.
    Williams NS, Bulstrode C et al (2008) Bailey and Love’s short practice of surgery, 25th edn. London, Edward ArnoldCrossRefGoogle Scholar
  8. 8.
    Textor J (2014) Platelet-rich plasma (PRP) as a therapeutic agent: platelet biology, growth factors and a review of the literature. In: Lana JF et al (eds) Lecture notes in bioengineering: platelet rich plasma. Springer; Berlin HeidelbergGoogle Scholar
  9. 9.
    Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23:177–189CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Rendu F, Brohard-Bohn B (2009) The platelet release reaction: granules’ constituents, secretion and functions. Platelets 12:261–273CrossRefGoogle Scholar
  11. 11.
    Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutaneous Aesthetic Surg 7:189–197CrossRefGoogle Scholar
  12. 12.
    Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA (2010) Platelet-rich plasma: where are we now and where are we going? Sports Health 2:203–210CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    International Cellular Medicine Society Platelet Rich Plasma Guidelines. http://www.cellmedicinesociety.org/attachments/370_Section%2010%20-%20Platelet%20Rich%20Plasma%20(PRP)%20Guidelines.pdf. Accessed 18 Jan 2016
  14. 14.
    White JG, Escolar G (2000) EDTA-induced changes in platelet structure and function: adhesion and spreading. Platelets 11:56–61CrossRefPubMedGoogle Scholar
  15. 15.
    ACD-A anticoagulant citrate dextrose solution, solution A : citra labs (n.d.) Retrieved 28 Jan 2016. From http://www.citra-labs.com/products/acd-a.cfm
  16. 16.
    Civinini R, Macera A, Nistri L, Redl B, Innocenti M (2011) The use of autologous blood-derived growth factors in bone regeneration. Clin Cases Mineral Bone Metab 8:25–31Google Scholar
  17. 17.
    Gulliksson H (2012) Platelets from platelet-rich-plasma versus buffy-coat-derived platelets: what is the difference? Rev Bras Hemat Hemoter 34:76–77CrossRefGoogle Scholar
  18. 18.
    Metcalfe P, Williamson LM, Reutelingsperger CP, Swann I, Ouwehand WH, Goodall AH (1997) Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Br J Haematol 98:86–95CrossRefPubMedGoogle Scholar
  19. 19.
    Dohan Ehrenfest DM, Andia I, Zumstein MA, Zhang C-Q, Pinto NR, Bielecki T (2014) Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Musc Ligament Tendon J 4:3–9Google Scholar
  20. 20.
    Sundman EA, Cole BJ, Fortier LA (2011) Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 39:2135–2140CrossRefPubMedGoogle Scholar
  21. 21.
    Anitua E, Zalduendo M, Troya M, Padilla S, Orive G (2015) Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One 10(3), e0121713CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89:780–785PubMedGoogle Scholar
  23. 23.
    Kammerlander C, Braito M, Kates S, Jeske C, Roth T, Blauth M, Dallapozza C (2012) The epidemiology of sports-related injuries in older adults: a central European epidemiologic study. Aging Clin Exp Res 24:448–454PubMedGoogle Scholar
  24. 24.
    Finch CF, Kemp JL, Clapperton AJ (2015) The incidence and burden of hospital-treated sports-related injury in people aged 15+ years in Victoria, Australia, 2004-2010: a future epidemic of osteoarthritis? Osteoarthritis Cartilage 23:1138–1143CrossRefPubMedGoogle Scholar
  25. 25.
    Pons-Villanueva J, Seguí-Gómez M, Martínez-González MA (2010) Risk of injury according to participation in specific physical activities: a 6-year follow-up of 14 356 participants of the SUN cohort. Int J Epidemiol 39:580–587CrossRefPubMedGoogle Scholar
  26. 26.
    Finch C, Costa AD, Stevenson M, Hamer P, Elliott B (2002) Sports injury experiences from the Western Australian sports injury cohort study. ANZ J Pub Health 26:462–467Google Scholar
  27. 27.
    Engebretsen L, Steffen K, Alsousou J, Anitua E, Bachl N, Devilee R et al (2010) IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med 44:1072–1081CrossRefPubMedGoogle Scholar
  28. 28.
    Laudy ABM, Bakker EWP, Rekers M, Moen MH (2015) Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br J Sports Med 49:657–672CrossRefPubMedGoogle Scholar
  29. 29.
    Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A (2013) Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 41:356–364CrossRefPubMedGoogle Scholar
  30. 30.
    Rees JD, Maffulli N, Cook J (2009) Management of tendinopathy. Am J Sports Med 37:1855–1867CrossRefPubMedGoogle Scholar
  31. 31.
    Dragoo JL, Wasterlain AS, Braun HJ, Nead KT (2014) Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 42:610–618CrossRefPubMedGoogle Scholar
  32. 32.
    Andia I, Rubio-Azpeitia E, Maffulli N (2015) Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes. Clin Orthop Relat Res 473:1624–1634Google Scholar
  33. 33.
    Liddle AD, Rodriguez-Merchan EC (2015) Platelet-rich plasma in the treatment of patellar tendinopathy: a systematic review. Am J Sports Med 43(10):2583–2590CrossRefPubMedGoogle Scholar
  34. 34.
    Ishida K, Kuroda R, Miwa M, Tabata Y, Hokugo A, Kawamoto T et al (2007) The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 13:1103–1112CrossRefPubMedGoogle Scholar
  35. 35.
    Zellner J, Mueller M, Berner A, Dienstknecht T, Kujat R, Nerlich M et al (2010) Role of mesenchymal stem cells in tissue engineering of meniscus. J Biomed Materials Res A 94:1150–1161Google Scholar
  36. 36.
    Griffin JW, Hadeed MM, Werner BC, Diduch DR, Carson EW, Miller MD (2015) Platelet-rich plasma in meniscal repair: does augmentation improve surgical outcomes? Clin Orthop Relat Res 473:1665–1672CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Pujol N, Salle De Chou E, Boisrenoult P, Beaufils P (2015) Platelet-rich plasma for open meniscal repair in young patients: any benefit? Knee Surg Sports Traumatol Arthrosc 23:51–58CrossRefPubMedGoogle Scholar
  38. 38.
    Bianco P, Robey PG, Simmons PJ (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2:313–319CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al (2005) Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393–395CrossRefPubMedGoogle Scholar
  40. 40.
    Can A (2008) A concise review on the classification and nomenclature of stem cells. Turkish J Hematol 25:57–59Google Scholar
  41. 41.
    Nielen MG, de Vries SA, Geijsen N (2013) European stem cell research in legal shackles. EMBO J 32:3107–3111CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676CrossRefPubMedGoogle Scholar
  43. 43.
    Heslop JA, Hammond TG, Santeramo I, Tort Piella A, Hopp I, Zhou J et al (2015) Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies. Stem Cells Transl Med 4:389–400CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Hui H, Tang Y, Hu M, Zhao X (2011) Stem cells : general features and characteristics. In: Stem cells in clinic and research. Intech, RijekaGoogle Scholar
  45. 45.
    Akhundov K, Pietramaggiori G, Waselle L, Darwiche S, Guerid S, Scaletta C et al (2012) Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Dis 25:207–213Google Scholar
  46. 46.
    Uccelli A, Moretta L, Pistoia V (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566–2573CrossRefPubMedGoogle Scholar
  47. 47.
    Ding D-C, Shyu W-C, Lin S-Z (2011) Mesenchymal stem cells. Cell Transplant 20:5–14CrossRefPubMedGoogle Scholar
  48. 48.
    Harichandan A, Bühring H-J (2011) Prospective isolation of human MSC. Best Pract Res Clin Haematol 24:25–36CrossRefPubMedGoogle Scholar
  49. 49.
    Biancone L, Bruno S, Deregibus MC, Tetta C, Camussi G (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27:3037–3042CrossRefPubMedGoogle Scholar
  50. 50.
    MacFarlane RJ, Graham SM, Davies PS, Korres N, Tsouchnica H, Heliotis M et al (2013) Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Exp Opin Therapeut Targets 17:243–254CrossRefGoogle Scholar
  51. 51.
    Shen Y, Fu Y, Wang J, Li G, Zhang X, Xu Y, Lin Y (2014) Biomaterial and mesenchymal stem cell for articular cartilage reconstruction. Curr Stem Cell Res Ther 9:254–267CrossRefPubMedGoogle Scholar
  52. 52.
    Veronesi F, Maglio M, Tschon M, Aldini NN, Fini M (2014) Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J Biomed Mat Rest A 102:2448–2466CrossRefGoogle Scholar
  53. 53.
    Khan WS, Johnson DS, Hardingham TE (2010) The potential of stem cells in the treatment of knee cartilage defects. Knee 17:369–374CrossRefPubMedGoogle Scholar
  54. 54.
    Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 10:199–206CrossRefPubMedGoogle Scholar
  55. 55.
    Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S (2004) Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13:595–600CrossRefPubMedGoogle Scholar
  56. 56.
    van Buul GM, Villafuertes E, Bos PK, Waarsing JH, Kops N, Narcisi R et al (2012) Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture. Osteoarthritis Cartilage 20:1186–1196CrossRefPubMedGoogle Scholar
  57. 57.
    Qi Y, Feng G, Yan W (2012) Mesenchymal stem cell-based treatment for cartilage defects in osteoarthritis. Mol Biol Rep 39:5683–5689CrossRefPubMedGoogle Scholar
  58. 58.
    Xia P, Wang X, Lin Q, Li X (2015) Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int Orthop 39:2363–2372CrossRefPubMedGoogle Scholar
  59. 59.
    Koh YG, Kwon OR, Kim YS et al (2014) Comparative outcomes of open-wedgehigh tibial osteotomy with platelet-richplasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30:1453–1460CrossRefPubMedGoogle Scholar
  60. 60.
    Rodríguez-Merchán EC (2014) Intra-articular injections of mesenchymal stem cells for knee osteoarthritis. Am J Orthop 43(E2):82–91Google Scholar
  61. 61.
    Yu H, Adesida AB, Jomha NM (2015) Meniscus repair using mesenchymal stem cells – a comprehensive review. Stem Cell Res Ther 6:86CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Pascual-Garrido C, Rolón A, Makino A (2012) Treatment of chronic patellar tendinopathy with autologous bone marrow stem cells: a 5-year-followup. Stem Cells Int 953510Google Scholar
  63. 63.
    Matsukura Y, Muneta T, Tsuji K, Koga H, Sekiya I (2014) Mesenchymal stem cells in synovial fluid increase after meniscus injury. Clin Orthop Relat Res 472:1357–1364CrossRefPubMedGoogle Scholar
  64. 64.
    Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H et al (2009) Intra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect. Stem Cells (Dayton, Ohio) 27:878–887Google Scholar
  65. 65.
    Horie M, Driscoll MD, Sampson HW, Sekiya I, Caroom CT, Prockop DJ, Thomas DB (2012) Implantation of allogenic synovial stem cells promotes meniscal regeneration in a rabbit meniscal defect model. J Bone Joint Surg Am 94:701–712CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Abdel-Hamid M, Hussein MR, Ahmad AF, Elgezawi EM (2005) Enhancement of the repair of meniscal wounds in the red-white zone (middle third) by the injection of bone marrow cells in canine animal model. Int J Exp Pathol 86:117–123CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Pak J, Lee JH, Lee SH (2014) Regenerative repair of damaged meniscus with autologous adipose tissue-derived stem cells. BioMed Res Int 2014:436029CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Vangsness CT, Farr J, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M (2014) Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J Bone Joint Surg Am 96:90–98CrossRefPubMedGoogle Scholar
  69. 69.
    Fu S-C, Cheuk Y-C, Yung S-H, Rolf CG, Chan K-M (2014) Systematic review of biological modulation of healing in anterior cruciate ligament reconstruction. Orthop J Sports Med 2(3):2325967114526687CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Silva A, Sampaio R, Fernandes R, Pinto E (2014) Is there a role for adult non-cultivated bone marrow stem cells in ACL reconstruction? Knee Surg Sports Traumatol Arthrosc 22:66–71Google Scholar
  71. 71.
    Figueroa D, Espinosa M, Calvo R, Scheu M, Vaisman A, Gallegos M, Conget P (2014) Anterior cruciate ligament regeneration using mesenchymal stem cells and collagen type I scaffold in a rabbit model. Knee Surg Sports Traumatol Arthrosc 22:1196–1202CrossRefPubMedGoogle Scholar
  72. 72.
    Proffen BL, Vavken P, Haslauer CM, Fleming BC, Harris CE, Machan JT, Murray MM (2015) Addition of autologous mesenchymal stem cells to whole blood for bioenhanced ACL repair has no benefit in the porcine model. Am J Sports Med 43:320–330CrossRefPubMedGoogle Scholar
  73. 73.
    Caudwell M, Crowley C, Khan WS, Wong JM-L (2014) Systematic review of preclinical and clinical studies on scaffold use in knee ligament regeneration. Curr Stem Cell Res Ther 10:11–18CrossRefGoogle Scholar
  74. 74.
    Fan H, Liu H, Wong EJW, Toh SL, Goh JCH (2008) In vivo study of anterior cruciate ligament regeneration using mesenchymal stem cells and silk scaffold. Biomaterials 29:3324–3337CrossRefPubMedGoogle Scholar
  75. 75.
    Shi P, Teh TKH, Toh SL, Goh JCH (2013) Variation of the effect of calcium phosphate enhancement of implanted silk fibroin ligament bone integration. Biomaterials 34:5947–5957CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of OrthopaedicsUniversity College London HospitalsLondonUK

Personalised recommendations